ORCHID PHARMA Fact Sheet, ORCHID PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA Fact Sheet    (ORCHID)


Our FREE Guide: Small Caps That Will Race Ahead of the Sensex


Here is the latest financial fact sheet of ORCHID PHARMA. For more details, see the ORCHID PHARMA quarterly results and ORCHID PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA Price History

Price Rs 294.6
Mkt Cap Rs m 12,022
Vol '000 1.0
P/E X -19.9
P/CF X -157.9
EPS (TTM) Rs -14.8
1 Day % 3.6
No. of shares m 40.82
1 Week % -2.2
1 Month % -21.2
1 Year % -79.8
52 week H/L Rs 1,490.0/260.2
As on May 27, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA EQUITY SHARE DATA
High Rs46401482,465 
Low Rs24113418 
Sales per share (Unadj.) Rs88.376.267.4118.5110.3 
Earnings per share (Unadj.) Rs-55.1-39.77.8-32.1-28.5 
Diluted earnings per shareRs-120.2-86.417.0-32.1-28.5 
Cash flow per share (Unadj.) Rs-39.3-24.722.4-3.2-1.9 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs-43.6-89.0-79.1187.6159.9 
Adj. book value per shareRs-95.0-194.0-172.5187.7160.0 
Shares outstanding (eoy) m88.9688.9688.9640.8240.82 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x0.40.30.10.111.3 
Avg P/E ratio x-0.6-0.61.1-0.2-43.5 
P/CF ratio (eoy) x-0.9-1.00.4-1.9-665.6 
Price / Book Value ratio x-0.8-0.3-0.107.8 
Dividend payout %00000 
Avg Mkt Cap Rs m3,0962,24974224950,677 
No. of employees `000NANANANANA 
Total wages/salary Rs m803862823749671 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
ORCHID PHARMA INCOME DATA
Net Sales Rs m7,8566,7826,0004,8384,501 
Other income Rs m192203169243152 
Total revenues Rs m8,0476,9856,1695,0814,653 
Gross profit Rs m-8562431,891-312294 
Depreciation Rs m1,4101,3331,2991,1791,089 
Interest Rs m3,3113,1036762522 
Profit before tax Rs m-5,385-3,990694-1,311-1,165 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-480-462000 
Profit after tax Rs m-4,905-3,528694-1,311-1,165 
Gross profit margin %-10.93.631.5-6.46.5 
Effective tax rate %8.911.6000 
Net profit margin %-62.4-52.011.6-27.1-25.9 
ORCHID PHARMA BALANCE SHEET DATA
Current assets Rs m8,7916,7897,6755,6935,499 
Current liabilities Rs m15,40720,12523,4551,7491,421 
Net working cap to sales %-84.2-196.6-263.081.590.6 
Current ratio x0.60.30.33.33.9 
Inventory Days Days322424472520 
Debtors Days Days9436437295131,101 
Net fixed assets Rs m24,78924,46423,0968,9066,874 
Share capital Rs m890890890408408 
"Free" reserves Rs m-4,766-8,807-7,9307,2526,121 
Net worth Rs m-3,877-7,918-7,0407,6606,529 
Long term debt Rs m21,56818,93914,2465,0404,275 
Total assets Rs m33,58031,25430,77014,59912,373 
Interest coverage x-0.6-0.311.4-20.0-1.2 
Debt to equity ratio x-5.6-2.4-2.00.70.7 
Sales to assets ratio x0.20.20.20.30.4 
Return on assets %-4.7-1.42.5-8.6-5.2 
Return on equity %126.544.6-9.9-17.1-17.8 
Return on capital %-11.7-8.010.6-9.8-6.0 
Exports to sales %71.173.880.091.388.1 
Imports to sales %26.922.628.131.337.3 
Exports (fob) Rs m5,5885,0024,7984,4163,966 
Imports (cif) Rs m2,1171,5341,6881,5141,677 
Fx inflow Rs m5,5885,0024,7984,4163,966 
Fx outflow Rs m2,8452,2531,8641,6051,729 
Net fx Rs m2,7432,7492,9342,8102,237 
ORCHID PHARMA CASH FLOW
From Operations Rs m 3,170 92 120 808 236 
From Investments Rs m -86 -281 455 1,671 672 
From Financial Activity Rs m -3,663 334 -3 -2,503 -1,650 
Net Cashflow Rs m -579 145 572 -24 -742 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 90.0%
Institution 4.6%
Non-Institution 5.4%
Total 100.0%
Free Float 10.0%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Orchid Towers, 313 Valluvar Kottam High Road, Nungambakkam, Chennai - 600034
E-mail corporate@orchidpharma.com/nikitak@orchidpharma.com Web www.orchidpharma.com
Tel 044-28211000/2824 4910 / 2824 4355 Fax 044-28211002
Sector PHARMACEUTICALS Group Private sector
Tr Agent Abhipra Capital Ltd, Abhipra Complex, A-387 Azadpur, Dilkush Indl.Area G T Karnal Road
Auditor SNB Associates
CHM: Ram Gopal Agarwal COMP SEC: Nikita K YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare ORCHID PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

Sensex Rallies 632 Points, Nifty Ends Above 16,350; Banking & IT Stocks Witness Buying(Closing)

Indian share markets rose today as easing bets about aggressive interest rate hikes by central banks lifted sentiment.

Views on news

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA 8-QTR ANALYSIS

COMPARE ORCHID PHARMA WITH

MARKET STATS